You are here

  • Home
  • Archive
  • Volume 11, Issue 3
  • Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare

Article metrics

Article menu
XML
Dermatology
Protocol
Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare

 

Online download statistics by month:

Online download statistics by month: March 2021 to April 2024

AbstractFullPdf
Mar 202120920927
Apr 2021384376226
May 2021256252129
Jun 2021252247152
Jul 202130730498
Aug 202115315568
Sep 202121020177
Oct 2021267269233
Nov 202113913192
Dec 202127027371
Jan 202217517480
Feb 202221622585
Mar 2022232224128
Apr 202219919067
May 202220319589
Jun 202218617762
Jul 202212111162
Aug 202213713274
Sep 2022196192103
Oct 202215914299
Nov 2022198215100
Dec 202211612250
Jan 202316314976
Feb 202313212475
Mar 202319318070
Apr 202314513258
May 202314512872
Jun 202315414560
Jul 202318016751
Aug 202318717155
Sep 202317316552
Oct 202321519869
Nov 202314412953
Dec 202316212378
Jan 2024888236
Feb 2024786632
Mar 20249791108
Apr 2024412836
Total688265943153